Sun Pharmaceutical Industries Ltd

NSE: SUNPHARMA · BSE: 524715 · Pharmaceuticals & Biotechnology · 72 announcements

Sun Pharmaceutical Industries Ltd news stories on ALFA NewsRead the news →

Share price: ₹1,902.30
Market cap: ₹4,56,426 Cr
Revenue (annual): ₹58,462 Cr
Net profit (annual): ₹11,479 Cr
P/E (TTM): 41.6×Sector 43.8×
Promoter holding: 52.68%-1.80% QoQ
FII holding: 14.36%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

26 Oct 2026 12:30 IST BSE

Sun Pharmaceutical Industries Debt & Borrowing: ₹7,816 Cr

Sun Pharma completed allotment of ₹7,816 crore NCDs via private placement, exercising its greenshoe option of ₹816 crore. The unsecured debentures carry 8.05–8.20% coupons maturing October 2031.

Value: ₹7,816 Cr
Execution: 5 years and 1 day (26 Oct 2026 to 27 Oct 2031)

Open announcement → Read the filing ↗

12 Oct 2026 19:56 IST BSE

Debt & Borrowing

Sun Pharmaceutical Industries Debt & Borrowing: ₹10,000 Cr

Sun Pharma's board approved issuing unsecured Non-Convertible Debentures up to ₹10,000 Crore. Additionally, Independent Director Mr. Gautam Doshi resigned from the company's board.

Value: ₹10,000 Cr

Open announcement → Read the filing ↗